Treatment of Fusobacterium nucleatum Pharyngitis

Introduction to F. nucleatum Pharyngitis

The Infectious Diseases Society of America (IDSA) guidelines state that the evidence for F. nucleatum as a primary pathogen in acute pharyngitis in adolescents and young adults is only suggestive, and further study is required to determine the necessity for and effectiveness of antibiotic therapy 1, 2, 3, 4
F. necrophorum, a closely related species, has been documented in throat swabs of adolescents and young adults with nonstreptococcal pharyngitis 1, 2, 3, 4
Some studies suggest a role for F. nucleatum in recurrent or persistent pharyngitis 1, 2, 3, 4
F. necrophorum is the causative agent of Lemierre's syndrome, which requires urgent antibiotic therapy 1, 2, 3, 4
No controlled studies demonstrate clinical response to antibiotic therapy for F. nucleatum pharyngitis 1, 2, 3, 4

The American College of Physicians and the Infectious Diseases Society of America recommend against routine antibiotic treatment for isolated F. nucleatum detected on throat swab in uncomplicated pharyngitis, but consider treatment if severe symptoms, persistent illness, or concern for progression to Lemierre's syndrome are present 1, 2, 3, 4
Consider treatment with metronidazole or amoxicillin-clavulanate if treatment is pursued due to severe symptoms, persistent illness, or concern for progression to Lemierre's syndrome 1, 2, 3, 4
Clindamycin is an alternative option, especially in penicillin allergy, as recommended by the Infectious Diseases Society of America 5, 6

Most pharyngitis in adolescents and young adults is viral, and detection of F. nucleatum may be incidental in a patient with viral pharyngitis 1, 2, 3, 4
Do not confuse colonization with infection, as F. nucleatum is part of normal oral flora, and its presence on throat swab may represent colonization rather than pathogenic infection 1, 2, 3, 4
Blood cultures should be obtained if fever persists beyond 48-72 hours or if systemic symptoms develop, as F. nucleatum can cause life-threatening bacteremia and metastatic infections 1, 2, 3, 4